Important: This article is for general education. It does not replace advice, diagnosis, or care from a qualified clinician. Decisions about prostate cancer screening are personal and should be made through an informed conversation with a clinician who can consider your health history, family history, symptoms, concerns, and preferences. [1] [2] [3] [4] [5]
Prostate cancer screening can be confusing because the goal is important, but the choice is not always simple. Screening may find cancer before it causes symptoms. At the same time, screening can lead to follow-up tests, worry, and treatment for cancers that might never have caused harm. A useful screening conversation looks at both sides.
This guide explains the purpose of prostate cancer screening, the prostate-specific antigen (PSA) test, what may happen after a result, possible benefits and harms, and questions to bring to a healthcare visit.
Understanding the prostate and prostate cancer
The prostate is a gland located below the bladder. It is part of the male reproductive system. Prostate cancer begins when cells in the prostate grow out of control. There are different kinds of prostate cancer, and some may grow slowly while others may behave more aggressively. [needs source]
Many people with prostate cancer do not have symptoms, especially early on. The Centers for Disease Control and Prevention notes that some people may have frequent urination, trouble urinating, blood in urine or semen, or pain in the back, hips, or pelvis. These symptoms can also be caused by conditions other than prostate cancer. A clinician can help assess the cause. [needs source]
Symptoms and screening are related but different. Screening is generally intended for people who do not have symptoms. If someone has new urinary symptoms, blood in urine or semen, persistent pain, or another concerning change, they should discuss it with a qualified clinician rather than assuming it is a screening question.
What prostate cancer screening is meant to do
Screening looks for signs of possible cancer before a person notices symptoms. The purpose is to identify cancers that may benefit from earlier attention. However, finding a cancer early does not always mean that finding it will improve a person’s health or length of life. Some prostate cancers grow very slowly and may never cause symptoms or problems. [needs source]
That is why prostate cancer screening is often described as a shared decision. Shared decision-making means that a patient and clinician review the available information together. The clinician explains possible benefits, limits, risks, and next steps. The patient shares what matters to them, including concerns about cancer, testing, uncertainty, procedures, and quality of life.
A screening decision is not a test of whether someone is being responsible about their health. Choosing screening, postponing screening, or deciding against screening can each be reasonable in different circumstances. The key is making an informed choice with appropriate medical guidance.
Screening is not the same as diagnosis
A screening test does not diagnose prostate cancer by itself. It identifies information that may need to be interpreted in context. An abnormal or unexpected screening result can have many explanations, including noncancerous prostate conditions. [needs source]
A diagnosis generally requires further evaluation. Depending on the situation, this may involve repeating a test, reviewing health history, performing an examination, ordering imaging, referring to a specialist, or considering a biopsy. A biopsy is a procedure in which small tissue samples are examined for cancer cells. [needs source]
The PSA test: what it measures and what it cannot tell you
The most commonly discussed screening test is the prostate-specific antigen, or PSA, blood test. PSA is a substance associated with prostate tissue that can be measured in blood. [needs source] A PSA result is not a simple “cancer” or “no cancer” answer.
PSA levels can be affected by factors other than prostate cancer. Noncancerous prostate enlargement, inflammation, infection, and other factors may affect a result. [needs source] Because of this, an elevated PSA result does not automatically mean cancer is present. Likewise, a PSA result that is not elevated does not guarantee that cancer is absent. [needs source]
A clinician may consider more than one PSA result over time, rather than relying on a single number alone. They may also consider age, overall health, symptoms, medicines, family history, ancestry, prior prostate testing, and other clinical details. The meaning of any result should be discussed with the clinician who ordered or reviews the test.
What about a digital rectal examination?
A digital rectal examination, often called a DRE, is an examination in which a clinician checks the prostate through the rectum using a gloved, lubricated finger. It may be used in some clinical evaluations. [needs source] Whether it is appropriate as part of a screening or diagnostic discussion can depend on the person and the clinician’s assessment.
It is reasonable to ask why an examination is being recommended, what it may add to the evaluation, what discomfort to expect, and whether there are alternatives or additional steps to consider.
Who may want to discuss screening earlier or more carefully?
Personal risk is an important part of the conversation. The CDC notes that, compared with other men, Black or African American men are more likely to develop prostate cancer, develop it at a younger age, have more advanced disease when it is found, and die from prostate cancer. A clinician can help place this information in the context of an individual’s situation.
Family history may also matter. A family history can include relatives who had prostate cancer or certain other cancers, particularly when cancer occurred at a younger age or affected multiple family members. The details of which relatives were affected and approximately when can help a clinician decide whether additional discussion is appropriate. [needs source]
Other considerations may include a person’s current health, other medical conditions, expected benefit from finding a cancer, and willingness to undergo follow-up testing if a screening result is uncertain. [needs source] Screening is not only about whether to have a blood test. It is also about whether a person would want and be able to consider the possible next steps.
Prepare your family history before the appointment
If possible, write down information before speaking with a clinician. You do not need a perfect family medical record. Even partial information can be useful.
- Which relatives have had prostate cancer or other cancers?
- How closely related are they to you?
- About how old were they when diagnosed?
- Do you know whether anyone had advanced cancer or died from cancer?
- Have any relatives had genetic testing, and do you know the result?
Do not delay a needed healthcare conversation because you do not have every detail. Bring what you know and explain what is uncertain.
Possible benefits of screening
A possible benefit of screening is finding a prostate cancer before symptoms develop. This may give a person and their care team more information and time to consider monitoring, additional testing, or treatment options when appropriate. [needs source]
For some people, learning about a cancer earlier may lead to care that helps prevent or reduce future harm. [needs source] However, the likelihood of benefit is not the same for every person. It can depend on the type of cancer, how quickly it is growing, a person’s health, and whether the cancer would have caused problems if it had not been found through screening. [needs source]
Some people value the opportunity to look for cancer early, even when results may be uncertain. Others place greater weight on avoiding unnecessary tests or treatment. Neither set of concerns should be dismissed. An informed conversation makes room for both.
Possible harms and limitations of screening
Screening has potential harms as well as possible benefits. Knowing about these harms can help a person decide whether screening fits their goals.
False-positive or unclear results
A false-positive result happens when a test suggests a possible problem even though cancer is not found. An unclear result may also lead to repeat testing, more appointments, imaging, specialist visits, or other evaluation. [needs source]
These steps can cause worry and may involve cost, time away from work or caregiving, travel, and physical discomfort. The emotional impact can be real even when follow-up ultimately does not show cancer.
Overdiagnosis
Overdiagnosis means finding a cancer that would not have caused symptoms or harm during a person’s lifetime. [needs source] This is a challenging idea because the word “cancer” naturally sounds urgent. Yet prostate cancers can differ greatly in how they behave.
Overdiagnosis can lead to overtreatment, meaning treatment for a cancer that may not have needed treatment. [needs source] It can also affect how a person sees their health and future, even if no immediate treatment is chosen.
Harms from follow-up tests and treatment
Further testing can have risks. A biopsy, for example, is a medical procedure and may have possible complications that should be discussed with the clinician performing or recommending it. [needs source] If cancer is diagnosed, treatment decisions can also involve potential effects on urinary, bowel, sexual, emotional, and general well-being. The specific risks differ by treatment approach and individual circumstances. [needs source]
It is appropriate to ask about these possibilities before agreeing to the next step. Asking questions is not a sign of distrust. It is part of informed consent and shared decision-making.
What may happen after a PSA result
There is no single path after a PSA test. The next step depends on the result, prior results, symptoms, risk factors, and the clinician’s judgment. A result that needs attention does not necessarily mean immediate treatment or even immediate invasive testing.
- Review the result in context. Ask what the result may mean for you and what other factors are being considered.
- Discuss whether repeat testing is appropriate. A clinician may sometimes want to confirm or better understand a result before moving to more involved testing. [needs source]
- Consider further evaluation if recommended. This can include referral to a clinician with prostate expertise, additional laboratory testing, imaging, examination, or biopsy. [needs source]
- Review the purpose and tradeoffs of each step. Before proceeding, ask what the test can and cannot show, what happens if it is normal or abnormal, and what risks it carries.
- Make decisions at a pace that is medically appropriate. If a clinician says a decision is not urgent, use the time to understand the choices, involve trusted family or support people, and consider a second opinion if desired.
If cancer is diagnosed, not every person will need the same approach. Some cancers may be monitored closely rather than treated immediately, while others may need more active care. [needs source] A qualified cancer care team can explain the options for a specific diagnosis.
Questions to ask a clinician about screening
Consider bringing these questions to an appointment. You may not need to ask all of them. Choose the ones that match your situation and concerns.
- Based on my health history, family history, and background, what is my risk of prostate cancer?
- What are the possible benefits of screening for someone like me?
- What are the possible harms or downsides of screening?
- What does the PSA test measure, and what can cause an abnormal result besides cancer?
- Would a single result be enough to make a decision, or might it need to be repeated?
- What would happen if my result were higher or lower than expected?
- Could screening lead to tests or procedures that I may not want?
- What are the possible risks of a biopsy or other follow-up testing?
- If cancer were found, how would we tell whether it needs treatment now or could be monitored?
- How might possible treatment affect daily life and quality of life?
- Would it be useful to speak with a specialist or seek a second opinion?
- What symptoms should prompt me to contact a clinician sooner?
How to have an informed conversation
A good screening conversation is honest about uncertainty. No screening test removes all uncertainty, and no clinician can promise a particular outcome. Still, a clear discussion can help people make choices that fit their values.
It may help to tell the clinician what matters most to you. For example, you may be especially concerned about missing a cancer, avoiding unnecessary procedures, preserving quality of life, understanding your family risk, or reducing uncertainty. These priorities can shape the discussion.
You can also bring a family member, friend, or caregiver to take notes if you wish. Ask for plain-language explanations of unfamiliar terms. If you need time, ask whether it is medically reasonable to review written information and return with questions.
Reliable educational sources can help you prepare, but online information cannot interpret your individual test results. Avoid making decisions based only on a headline, a social media post, or another person’s experience. A qualified clinician can help apply general information to your own circumstances.
When symptoms need medical attention
Because many prostate cancer symptoms can also occur with other conditions, symptoms should not be used to self-diagnose prostate cancer. Discuss persistent or concerning changes with a qualified clinician. The CDC lists frequent urination, trouble urinating, blood in urine or semen, and pain in the back, hips, or pelvis among symptoms that some men with prostate cancer may experience.
Seek timely medical guidance for symptoms that are new, worsening, severe, or concerning to you. A clinician can evaluate possible causes and explain whether prostate testing or another type of assessment is appropriate.
Key points to remember
- Prostate cancer screening is a personal healthcare decision, not a one-size-fits-all rule.
- The PSA blood test can provide useful information, but it cannot diagnose prostate cancer by itself.
- Possible benefits of screening should be weighed against possible harms, including false-positive results, follow-up procedures, overdiagnosis, and overtreatment. [needs source]
- Your family history, ancestry, overall health, symptoms, and preferences are important parts of the conversation.
- An abnormal result does not automatically mean cancer, and a normal result does not provide an absolute guarantee. [needs source]
- For personal guidance, speak with a qualified clinician who can explain your options and next steps.
Leave a Reply